IRIS
GIACOMELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.230
AS - Asia 11.767
EU - Europa 11.224
SA - Sud America 1.201
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 33
Totale 45.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.986
SG - Singapore 4.812
CN - Cina 2.661
IE - Irlanda 2.539
RU - Federazione Russa 2.099
TR - Turchia 1.522
IT - Italia 1.222
SE - Svezia 1.148
HK - Hong Kong 1.118
DE - Germania 1.060
BR - Brasile 1.031
VN - Vietnam 943
UA - Ucraina 831
GB - Regno Unito 741
FR - Francia 605
FI - Finlandia 393
NL - Olanda 219
IN - India 218
CA - Canada 138
JP - Giappone 100
BD - Bangladesh 90
BE - Belgio 64
AR - Argentina 63
ES - Italia 54
MX - Messico 50
ZA - Sudafrica 50
PL - Polonia 41
IQ - Iraq 36
EU - Europa 34
PK - Pakistan 28
RO - Romania 28
ID - Indonesia 27
AU - Australia 24
CZ - Repubblica Ceca 24
LT - Lituania 23
KR - Corea 22
MY - Malesia 22
CO - Colombia 21
EC - Ecuador 21
VE - Venezuela 20
GR - Grecia 19
MA - Marocco 18
AT - Austria 16
PH - Filippine 16
CH - Svizzera 15
EG - Egitto 15
NP - Nepal 15
DZ - Algeria 14
PT - Portogallo 14
JO - Giordania 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
BG - Bulgaria 12
SA - Arabia Saudita 12
TN - Tunisia 12
CL - Cile 11
JM - Giamaica 11
PE - Perù 11
IL - Israele 10
AL - Albania 9
BO - Bolivia 9
KE - Kenya 9
LB - Libano 9
NZ - Nuova Zelanda 9
CR - Costa Rica 8
DK - Danimarca 8
PY - Paraguay 8
QA - Qatar 8
ET - Etiopia 7
SN - Senegal 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
HR - Croazia 6
HU - Ungheria 6
KZ - Kazakistan 6
MK - Macedonia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
HN - Honduras 5
IR - Iran 5
KW - Kuwait 5
NI - Nicaragua 5
RS - Serbia 5
TW - Taiwan 5
GE - Georgia 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 45.611
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.347
Chandler 2.675
Singapore 2.579
Dublin 2.531
San Jose 2.045
Dallas 1.392
Ashburn 1.112
Hong Kong 1.099
Santa Clara 1.047
Boardman 995
Izmir 831
Council Bluffs 580
Nanjing 554
The Dalles 527
San Mateo 512
Wilmington 499
Moscow 447
Lawrence 444
Princeton 444
New York 440
Beijing 376
Ann Arbor 291
Ho Chi Minh City 291
Lauterbourg 253
Nanchang 221
Hanoi 208
Los Angeles 194
Milan 187
Amsterdam 176
L'aquila 164
L’Aquila 162
Dearborn 143
Woodbridge 137
Seattle 133
Verona 122
Hefei 121
Des Moines 119
Shenyang 119
Hebei 103
São Paulo 95
Tokyo 94
Kunming 90
Tianjin 90
Jiaxing 84
Frankfurt am Main 80
Shanghai 79
Munich 78
Mountain View 65
Helsinki 62
Changsha 60
Columbus 60
Dong Ket 60
Rome 60
Brussels 57
Jinan 57
Zhengzhou 56
Norwalk 55
Orem 48
Chicago 45
Hangzhou 43
Phoenix 42
Philadelphia 41
Da Nang 40
Montreal 40
Haiphong 38
Houston 38
Pune 37
San Francisco 37
Rio de Janeiro 36
Ningbo 34
Guangzhou 33
Warsaw 33
Brooklyn 32
Johannesburg 31
London 28
Atlanta 27
Toronto 27
Belo Horizonte 26
Chennai 26
Stockholm 25
Denver 24
Mumbai 24
Manchester 23
Kitzingen 21
Lanzhou 21
Brno 19
New Delhi 19
Pescara 19
Boston 17
Bremen 17
Mexico City 17
Taizhou 17
Ankara 16
Bucharest 16
Redwood City 16
Brasília 15
Charlotte 15
Falkenstein 15
Washington 15
Baghdad 14
Totale 30.069
Salva come PNG Salva come JPEG
Nome #
------- 350
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 284
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 203
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 185
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 182
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 175
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 161
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 160
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 158
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 157
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 156
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 155
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 154
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 152
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 150
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 148
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 145
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 144
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 144
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 143
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 143
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 142
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 140
Cardiovascular disease in primary sjögren’s syndrome 139
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 139
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 138
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 138
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 137
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 137
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 136
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 135
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 133
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 133
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 133
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 132
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 132
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis 132
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 131
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 130
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 130
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 128
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 128
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 128
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 127
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 127
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 127
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 127
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 126
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 126
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 125
Stem cell therapies for systemic sclerosis 124
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 124
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 124
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 124
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 123
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 123
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 123
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 122
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 122
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 122
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 122
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. 122
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 122
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 122
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 121
A comprehensive review on adult onset Still's disease 121
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 121
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 120
Malattie dell'apparato cardiovascolare 120
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 119
ALTERAZIONI DELLE SOTTOPOLAZIONI LINFOCITARIE IN CORSO DI SCLERODERMIA 119
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 119
Diagnostic and interventional radiology fundamentals of synovial pathology 119
Cytokine production in patients with monoclonal gammapathies. 119
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 118
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 118
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 118
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 118
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 118
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 117
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells 117
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 117
Inosine pranobex in the combination therapy of HIV infection. 117
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 117
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 117
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 117
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 116
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 116
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 116
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 116
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 115
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 115
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 115
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 115
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 115
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 115
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 115
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 115
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 114
Totale 13.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 200.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.529 134 240 441 174 103 26 21 152 189 131 179 739
2022/20237.628 605 368 158 745 734 854 15 537 3.241 57 213 101
2023/20241.937 418 114 116 257 149 476 33 103 10 81 52 128
2024/20257.471 135 151 757 232 840 631 975 632 1.824 304 480 510
2025/202613.745 692 1.366 712 1.557 1.195 1.175 2.629 594 1.388 1.245 974 218
2026/2027282 282 0 0 0 0 0 0 0 0 0 0 0
Totale 46.116